Stay updated on 89Zr-Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 89Zr-Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page revision label updates from **v3.5.2** to **v3.5.3**, indicating a site/version release with no change to the study’s informational content.
    Difference
    0.1%
    Check dated 2026-04-24T05:50:06.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:13:13.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Added a new version label 'Revision: v3.5.0' and removed 'Revision: v3.4.3' from the site metadata.
    Difference
    0.1%
    Check dated 2026-03-19T05:06:53.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor site version update with no visible changes to core content or functionality.
    Difference
    0.1%
    Check dated 2026-03-12T02:25:26.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding-lapse notice along with Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T11:32:22.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a site-wide government funding lapse notice indicating possible delays in updates and support availability. Updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:29:13.000Z thumbnail image

Stay in the know with updates to 89Zr-Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.